Though low cost playing cards may also help ease the burden of higher drug expenditures inside the short-term, they don't handle the systemic difficulties driving up prescription price ranges in the U.S. Broader coverage improvements could deal with the foundation leads to of growing drug charges, for example not enough transparency in pricing and